Skip to main content

Table 3 Performance of iELISA using rOmp2a antigen

From: Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis

S.No. Group Positive by iELISA Negative by iELISA
1 I 14(93.3%) 1(6.66%)
2 II 23(82.1%), 25(96.1%) 5(17.8%), 1(3.8%)
3 III 1(3.8%), 3(9.37%) 25(96.1%), 29(90.6%)
4 IV 2(5.7%) 33(94.2%)
5 V 1(4.3%) 22(95.6%)